AHA 2020

2020-11-13 - 2020-11-17
Online, Virtual

ESC 2020

2020-08-29 - 2020-09-01
Online, Virtual

ESH 2020

2020-05-29 - 2020-06-01
Online, Virtual

ESC 2019

2019-08-31 - 2019-09-04
Paris, France

ACC 2019

2019-03-17 - 2019-03-19
New Orleans, LA, United States

AHA 2018

2018-11-10 - 2018-11-12
Chicago, United States

ESC 2018

2018-08-25 - 2018-07-29
Munich, Germany

ESC Heart Failure 2018

2018-05-26 - 2018-05-29
Vienna, Austria
Search in Scientific Content:
Date
Filters:
From Trial
13:26

From Trials to Bedside: Filling the Gaps in Implementing Evidence-based Care

Presenter: Paul Whelton
AHA 2020
Coronary A
9:57

Coronary Artery Disease: What was new at ESC Congress 2020?

Presenter: Stephan Achenbach
2020 Scientific Congress of the Hungarian Society of Cardiology
State of t
8:34

State of the Science: The Six Pillars of Heart Failure Therapy

Presenter: Marc A. Pfeffer
AHA 2020
A Polypill
13:09

A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3

Presenter: Prem Pais
AHA 2020
Prevalence
11:30

Prevalence and Prediction of Coronary Artery Disease in the General Population- Results From the Swedish Cardiopulmonary Bioimage Study (scapis)

Presenter: Pamela S. Douglas
AHA 2020
A Three-ar
9:01

A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial

Presenter: Francine Welty
AHA 2020
Putting it
6:47

Putting it all Together in Lipid Therapy

Presenter: Karol Watson
AHA 2020
3-year Cli
7:04

3-year Clinical Outcomes in a Nationwide, Randomized, Pragmatic Clinical Trial of Atrial Fibrillation Screening - Mhealth Screening to Prevent Strokes (mstops)

Presenter: Steven Steinhubl
AHA 2020
High Dose
8:57

High Dose versus Standard Dose Influenza Vaccine in Patients With High Risk Cardiovascular Disease: Results From the Invested Trial

Presenter: Orly Vardeny
AHA 2020
Rate versu
3:55

Rate versus Rhythm Control - lessons learned from EAST

Presenter: Paulus Kirchhof
AHA 2020
The Vital
6:41

The Vital Rhythm Trial: Omega-3 Fatty Acid and Vitamin D Supplementation in the Primary Prevention of Atrial Fibrillation

Presenter: Renate Schnabel
AHA 2020
The AHA CO
12:45

The AHA COVID-19 Cardiovascular Disease Registry: Design, Implementation, and Initial Results

Presenter: James de Lemos
AHA 2020
Early Inva
13:22

Early Invasive Intervention for Atrial Fibrillation

Presenter: Jason Andrade
AHA 2020
Scientific
10:58

Scientific Organisations in the COVID-era: What Can Be Done, What Should Be Done?

Presenter: Barbara Casadei
2020 Scientific Congress of the Hungarian Society of Cardiology
ESC ATLAS ...
15:50

ESC ATLAS – Much More Than Bearing the CVD Burden

Presenter: Dan Gaita
2020 Scientific Congress of the Hungarian Society of Cardiology
Revascular
11:07

Revascularization for Chronic Coronary Syndromes

Presenter: Franz Weidinger
2020 Scientific Congress of the Hungarian Society of Cardiology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
HOPE 4 - I
5:19

HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

Presenter: J.D. Schwalm
SYNTAXES:
7:28

SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study

Presenter: Daniel Johannes Franciscus Maria Thuijs
MITRA-FR -
8:46

MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation

Presenter: Jean-Francois Obadia
DAPA HF Th
6:20

DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

Presenter: John McMurray
CONDI-2/ER
4:010

CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Presenter: Hans Erik Botker